| Founder effect is responsible for the p. Leu131Phe heparin‐binding‐site antithrombin mutation common in Hungary: phenotype analysis in a large cohort R Gindele, Z Oláh, P Ilonczai, M Speker, Á Udvari, A Selmeczi, G Pfliegler, ... Journal of Thrombosis and Haemostasis 14 (4), 704-715, 2016 | 51 | 2016 |
| The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency B Kovács, Z Bereczky, Z Oláh, R Gindele, A Kerényi, A Selmeczi, Z Boda, ... American journal of clinical pathology 140 (5), 675-679, 2013 | 34 | 2013 |
| Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center R Gindele, A Selmeczi, Z Oláh, P Ilonczai, G Pfliegler, E Marján, L Nemes, ... Thrombosis research 160, 119-128, 2017 | 24 | 2017 |
| Factor XIII B subunit polymorphisms and the risk of coronary artery disease ZA Mezei, Z Bereczky, É Katona, R Gindele, E Balogh, S Fiatal, L Balogh, ... International journal of molecular sciences 16 (1), 1143-1159, 2015 | 23 | 2015 |
| Deficiencies of the natural anticoagulants–novel clinical laboratory aspects of thrombophilia testing Z Bereczky, R Gindele, M Speker, J Kállai Ejifcc 27 (2), 130, 2016 | 19 | 2016 |
| Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients L Balogh, É Katona, ZA Mezei, J Kállai, R Gindele, I Édes, L Muszbek, ... Molecular and cellular biochemistry 448 (1), 199-209, 2018 | 18 | 2018 |
| Molecular characterization of p. Asp77Gly and the novel p. Ala163Val and p. Ala163Glu mutations causing protein C deficiency KB Kovács, I Pataki, H Bárdos, A Fekete, G Pfliegler, G Haramura, ... Thrombosis research 135 (4), 718-726, 2015 | 16 | 2015 |
| Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies B Kovács, Z Bereczky, A Selmeczi, R Gindele, Z Oláh, A Kerényi, Z Boda, ... Clinical Chemistry and Laboratory Medicine (CCLM) 52 (12), 1797-1806, 2014 | 16 | 2014 |
| Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods R Gindele, K Pénzes-Daku, G Balogh, J Kállai, R Bogáti, B Bécsi, ... Biomolecules 11 (4), 544, 2021 | 13 | 2021 |
| High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous Antithrombin Budapest 3 variant: description of a new syndrome ME de la Morena‐Barrio, R Gindele, C Bravo‐Pérez, P Ilonczai, I Zuazu, ... American Journal of Hematology, 2021 | 10 | 2021 |
| Age and origin of the founder Antithrombin Budapest 3 (p. Leu131Phe) mutation; its high prevalence in the Roma population and its association with cardiovascular diseases Z Bereczky, R Gindele, S Fiatal, M Speker, T Miklós, L Balogh, Z Mezei, ... Frontiers in Cardiovascular Medicine 7, 419, 2021 | 10 | 2021 |
| Evidence for the founder effect of a novel ACVRL1 splice‐site mutation in Hungarian hereditary hemorrhagic telangiectasia families T Major, R Gindele, Z Szabó, T Alef, B Thiele, L Bora, Z Kis, P Bárdossy, ... Clinical genetics 90 (5), 466-467, 2016 | 9 | 2016 |
| Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next … R Gindele, A Kerényi, J Kállai, G Pfliegler, Á Schlammadinger, I Szegedi, ... Life 11 (3), 202, 2021 | 8 | 2021 |
| Founder Effects in Hereditary Hemorrhagic Telangiectasia T Major, R Gindele, G Balogh, P Bárdossy, Z Bereczky Journal of clinical medicine 10 (8), 1682, 2021 | 6 | 2021 |
| Antithrombin Debrecen (p. Leu205Pro)–Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency A Selmeczi, R Gindele, P Ilonczai, A Fekete, I Komáromi, ... Thrombosis research 158, 1-7, 2017 | 6 | 2017 |
| rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics G Remenyi, Z Bereczky, R Gindele, A Ujfalusi, A Illes, M Udvardy Pathology and Oncology Research 27, 2021 | 5 | 2021 |
| Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary T Major, Z Bereczky, R Gindele, G Balogh, B Rácz, L Bora, Z Kézsmárki, ... Journal of Clinical Medicine 10 (17), 3774, 2021 | 4 | 2021 |
| The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia T Major, R Gindele, Z Szabó, Z Kis, L Bora, N Jóni, P Bárdossy, T Rácz, ... Pathology & Oncology Research, 1-6, 2019 | 4 | 2019 |
| Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia T Major, C Csobay-Novák, R Gindele, Z Szabó, L Bora, N Jóni, T Rácz, ... Journal of International Medical Research 48 (2), 0300060519860971, 2020 | 3 | 2020 |
| A herediter haemorrhagiás teleangiectasia (Osler–Weber–Rendu-kór) genetikai diagnosztikája T Major, R Gindele, Z Szabó, N Jóni, Z Kis, L Bora, P Bárdossy, T Rácz, ... Orvosi Hetilap 160 (18), 710-719, 2019 | 2 | 2019 |
